| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 28.09.2001 (8253
dage). |
Ingen historik.
| Branche | | Ventureselskaber og kapitalfonde (643040). |
| Sidst opdateret den 22.12.2007 og
angivet som gældende fra 01.01.2008 (5967
dage). |
| Historik | Start | Stop |
|---|
| Ventureselskaber og kapitalfonde (643040) | 01.01.2008 | |
| Ventureselskaber (652325) | 01.01.2003 | 31.12.2007 |
| Investeringsselskaber (652320) | 28.09.2001 | 31.12.2002 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 28.09.2001 (8253
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | NORDIC BIOTECH K/S. |
| Sidst opdateret den 22.11.2013 og
angivet som gældende fra 28.09.2001 (8253
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af komplementaren. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 27.05.2014 (3629
dage). |
| Fortolkning
(1 tegningsmulighed)
| | komplementaren |
Ingen historik.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for opinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion
Konklusion (revision):OpinionWe have audited the financial statements of Nordic Biotech K/S for the financial year 1 January – 31 December 2022 which comprise an income statement balance sheet statement of changes in equity and notes including accounting policies The financial statements are prepared in accordance with the Danish Financial Statements ActIn our opinion the financial statements give a true and fair view of the financial position of the Limited Partnership at 31 December 2022 and of the results of the Limited Partnership's operations for the financial year 1 January – 31 December 2022 in accordance with the Danish Financial Statements Act
Udtalelse om ledelsesberetningen (revision):Statement on the Management's reviewManagement is responsible for the Management's reviewOur opinion on the financial statements døs not cover the Management's review and we do not express any form of assurance conclusion thereonIn connection with our audit of the financial statements our responsibility is to read the Management's review and in doing so consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit or otherwise appears to be materially misstatedMoreover it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements ActBased on the work we have performed we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act We did not identify any material misstatement of the Management's review
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration